Post Profile






Momentum Carries Lululemon Lower, Pushes Biotech Names Higher

Two biotechs and a technology company are among the three momentum charts to watch today, with the lone short being a retailer. Array BioPharma (ARRY) had an explosive move on Monday, up $2.96, or 81%, to $6.61, on 101 million shares. The company said its melanoma treatments met its primary goal in a late-stage trial. […]
read more

share

Related Posts


Array Biopharma Inc (ARRY), Vertex Pharmaceuticals Incorporated (VRTX): This Week in Biotech

Business & Finance / Investing : Insider Monkey

With the SPDR S&P Biotech Index up 29% over the trailing-12-month period, it’s evident that investment dollars are willingly flowing into the biotech sector. Keeping that in mind, let’s have a look at some of the rulings, studies, a...

Stocks rise, led by tech and consumer companies

Business & Finance : Money & Co

U.S. stocks are rising in Tuesday morning trading as technology and consumer companies move higher. Energy companies are falling as the price of oil returns some of Monday's gains. Bond prices continue to rise and yields continue to...

Biotech names lift the Nasdaq

Business & Finance : Business Report

American stocks rose on Monday, with a rally in high-growth names among Internet and biotech shares giving the Nasdaq a gain of almost one percent. ||| New York - US stocks rose on Monday, with a rally in high-growth names among Int...

Biotech Company Hemispherx Goes Nuts After Announcing Collaboration With US On Ebola Treatment (HEB, TKMR)

Business & Finance : Business Insider: Money Game

A possible Ebola treatment is making the stock of yet another company go nuts. Shares of Hemispherx Biopharma, a small biotech company with a market cap of just $50 million, were up as much as 26% in pre-market trade on Monday after...

Array Biopharma Inc (ARRY), AstraZeneca plc (ADR) (AZN), GlaxoSmithKline plc (ADR) (GSK): This Cancer Biotech Is Looking for Other Green Pastures

Business & Finance / Investing : Insider Monkey

Array Biopharma Inc (NASDAQ:ARRY), a biotech company primarily focused on discovery of drugs for cancer treatment, is making forays into the asthma market. The company recently announced encouraging results – 6.8% improvement in FEV...

Comments


Copyright © 2016 Regator, LLC